The effectiveness of these two drugs in PPMS cases with EWSR1::CREB1 fusion remains uncertain, and further data are needed to determine their suitability for treating PPMS with EWSR1::CREB1 fusion. The gene discussed is CREB1; the disease is primary progressive multiple sclerosis.